News
-
DRDO develops COVID-19 antibody detection kit
DRDO develops COVID-19 antibody detection kit | Source: Ministry of Defence Defence Institute of Physiology and Allied Sciences (DIPAS), a…
Read More » -
Remembering Shri Sunderlal Bahuguna
Environmentalist Sunderlal Bahuguna, who died on 21 May 2021. | Source: Twitter/@kuljitnagra1 Sunderlal Bahuguna (9 January 1927 – 21 May…
Read More » -
Vaccination Drive by POWERGRID
POWERGRID Corporation of India Ltd, a Maharatna PSU under the Ministry of Power, has organised vaccination camps in many locations…
Read More » -
INS Rajput to be Decommissioned on 21 May 21
INS Rajput | Source: Ministry of Defence On the 21st of May, a glorious era will come to an end…
Read More » -
Oxygen Expresses deliver nearly 11800 MT of Liquid Medical Oxygen
Oxygen Expresses | Source: Twitter Overcoming all hurdles and finding new solutions, Indian Railways is continuing its journey of bringing…
Read More » -
Indian Army innovate the conversion of liquid oxygen to low-pressure oxygen for COVID patients
Indian Army innovate the conversion of liquid oxygen to low-pressure oxygen for COVID patients | Source: Ministry of Defence As…
Read More » -
Prime Minister undertakes aerial survey of Cyclone Tauktae affected areas in Gujarat
PM Modi reviews damages caused by Cyclone Tauktae (ANI) Prime Minister Shri Narendra Modi today visited Gujarat to review the situation…
Read More » -
Shri Rajnath Singh unveils DRDO developed anti-COVID drug
Shri Rajnath Singh unveils DRDO developed anti-COVID drug | Source: Ministry of Defence The first batch of the adjunct COVID…
Read More » -
Efforts to ensure availability of Remdesivir in India
A lab technician holds the coronavirus disease (COVID-19) treatment drug “Remdesivir” at Eva Pharma Facility in Cairo. © Reuters Department…
Read More » -
Mega make-shift COVID centre set up at Kochi Refinery premises
A 100-bed make-shift COVID treatment centre opened today at BPCL’s Kochi Refinery operated school, adjacent to its premises, in Ambalamugal,…
Read More » -
DCGI approves Phase II/III clinical trial of COVAXIN in the age group of 2 to 18 Years
The National Regulator of the country, the Drugs Controller General of India (DCGI), after careful examination, has accepted the recommendation…
Read More » -
Gap between two doses of Covishield Vaccine extended from 6-8 weeks to 12-16 weeks
The COVID Working Group chaired by Dr N K Arora has recommended extension of the gap between the first and…
Read More » -
More than 1500 doctors serve patients remotely through eSanjeevani telemedicine platform
In around a little over one year eSanjeevani, the flagship National Telemedicine Service of MoHFW has served more than 50…
Read More »